HEADER HYDROLASE/HYDROLASE INHIBITOR 27-FEB-02 1GVU TITLE ENDOTHIAPEPSIN COMPLEX WITH H189 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHIAPEPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTATE PROTEASE; COMPND 5 EC: 3.4.23.22; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INHIBITOR, H189; COMPND 8 CHAIN: I; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENDOTHIA PARASITICA; SOURCE 3 ORGANISM_COMMON: CHESTNUT BLIGHT FUNGUS; SOURCE 4 ORGANISM_TAXID: 5116; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 8 ORGANISM_TAXID: 32630 KEYWDS HYDROLASE, ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, Z KEYWDS 2 TETRAHEDRAL INTERMEDIATE, ANISOTROPIC REFINEMENT, ASPARTYL P, KEYWDS 3 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.COATES,P.T.ERSKINE,M.P.CRUMP,S.P.WOOD,J.B.COOPER REVDAT 4 15-NOV-23 1GVU 1 SOURCE REMARK LINK ATOM REVDAT 3 13-JUL-11 1GVU 1 VERSN REVDAT 2 24-FEB-09 1GVU 1 VERSN REVDAT 1 04-JUL-02 1GVU 0 JRNL AUTH L.COATES,P.T.ERSKINE,M.P.CRUMP,S.P.WOOD,J.B.COOPER JRNL TITL FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN JRNL TITL 2 INHIBITOR COMPLEXES: IMPLICATIONS FOR THE ASPARTIC JRNL TITL 3 PROTEINASE MECHANISM JRNL REF J.MOL.BIOL. V. 318 1405 2002 JRNL REFN ISSN 0022-2836 JRNL PMID 12083527 JRNL DOI 10.1016/S0022-2836(02)00197-3 REMARK 2 REMARK 2 RESOLUTION. 0.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.2 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.115 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.116 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.139 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 7335 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 139281 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.111 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.112 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.135 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 6687 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 126764 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2442 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 462 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.022 REMARK 3 ANGLE DISTANCES (A) : 0.041 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.094 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.112 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.047 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.006 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.033 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.094 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS AND KRETSINGER REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GVU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-FEB-02. REMARK 100 THE DEPOSITION ID IS D_1290009476. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-01 REMARK 200 TEMPERATURE (KELVIN) : 130.0 REMARK 200 PH : 4.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 149856 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.980 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.15800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 4.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.88950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYTIC ACTIVITY: HYDROLYSIS OF PROTEINS SIMILAR TO PEPSIN A REMARK 400 REMARK 400 THE H 189 IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: H 189 REMARK 400 CHAIN: I REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO I 401 REMARK 465 HIS I 402 REMARK 465 HIS I 409 REMARK 465 LYS I 410 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 33 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 33 CB - CG - OD2 ANGL. DEV. = -6.6 DEGREES REMARK 500 PHE A 34 CB - CG - CD2 ANGL. DEV. = -4.5 DEGREES REMARK 500 SER A 45 N - CA - CB ANGL. DEV. = -9.9 DEGREES REMARK 500 SUI A 54 CA - C - N ANGL. DEV. = -45.7 DEGREES REMARK 500 ASP A 119 CB - CG - OD1 ANGL. DEV. = 7.5 DEGREES REMARK 500 ASP A 119 CB - CG - OD2 ANGL. DEV. = -10.0 DEGREES REMARK 500 ASP A 146 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 TYR A 277 CB - CG - CD2 ANGL. DEV. = -5.1 DEGREES REMARK 500 ASP A 307 CB - CG - OD1 ANGL. DEV. = -5.4 DEGREES REMARK 500 PHE I 404 CB - CG - CD2 ANGL. DEV. = 5.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 129 -169.12 -78.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 STA I 406 VAL I 407 -117.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 STA I 406 30.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2083 DISTANCE = 6.18 ANGSTROMS REMARK 525 HOH A2105 DISTANCE = 6.01 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF INHIBITOR, H189 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E5O RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH INHIBITOR DB2 REMARK 900 RELATED ID: 1E80 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA- EMD56133 REMARK 900 RELATED ID: 1E81 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA- EMD61395 REMARK 900 RELATED ID: 1E82 RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA- EMD59601 REMARK 900 RELATED ID: 1EED RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH THE CYCLOHEXYL RENIN INHIBITOR PD125754 REMARK 900 RELATED ID: 1ENT RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH THE INHIBITOR PD130328 REMARK 900 RELATED ID: 1EPL RELATED DB: PDB REMARK 900 RELATED ID: 1EPM RELATED DB: PDB REMARK 900 RELATED ID: 1EPN RELATED DB: PDB REMARK 900 RELATED ID: 1EPO RELATED DB: PDB REMARK 900 RELATED ID: 1EPP RELATED DB: PDB REMARK 900 RELATED ID: 1EPQ RELATED DB: PDB REMARK 900 RELATED ID: 1EPR RELATED DB: PDB REMARK 900 RELATED ID: 1ER8 RELATED DB: PDB REMARK 900 RELATED ID: 1GKT RELATED DB: PDB REMARK 900 NEUTRON LAUE DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH REMARK 900 TRANSITION STATE ANALOGUE INHIBITOR H261 REMARK 900 RELATED ID: 1GVT RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH CP-80,794 REMARK 900 RELATED ID: 1GVV RELATED DB: PDB REMARK 900 FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN INHIBITOR REMARK 900 COMPLEXES; IMPLICATIONS FOR THE ASPARTIC PROTEINASE MECHANISM REMARK 900 RELATED ID: 1GVW RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEX WITH PD-130,328 REMARK 900 RELATED ID: 1GVX RELATED DB: PDB REMARK 900 ENDOTHIAPEPSIN COMPLEXED WITH H256 REMARK 900 RELATED ID: 2ER0 RELATED DB: PDB REMARK 900 RELATED ID: 2ER6 RELATED DB: PDB REMARK 900 RELATED ID: 2ER7 RELATED DB: PDB REMARK 900 RELATED ID: 2ER9 RELATED DB: PDB REMARK 900 RELATED ID: 3ER3 RELATED DB: PDB REMARK 900 RELATED ID: 3ER5 RELATED DB: PDB REMARK 900 RELATED ID: 4APE RELATED DB: PDB REMARK 900 RELATED ID: 4ER1 RELATED DB: PDB REMARK 900 RELATED ID: 4ER2 RELATED DB: PDB REMARK 900 RELATED ID: 4ER4 RELATED DB: PDB REMARK 900 RELATED ID: 5ER1 RELATED DB: PDB REMARK 900 RELATED ID: 5ER2 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 MODRES: 1GVU SUI A 54() ASP, GLY HAVE CYCLISED TO FORM A REMARK 999 SUCCINIMIDE DBREF 1GVU A 1 330 UNP P11838 CARP_CRYPA 90 419 DBREF 1GVU I 401 410 PDB 1GVU 1GVU 401 410 SEQRES 1 A 329 SER THR GLY SER ALA THR THR THR PRO ILE ASP SER LEU SEQRES 2 A 329 ASP ASP ALA TYR ILE THR PRO VAL GLN ILE GLY THR PRO SEQRES 3 A 329 ALA GLN THR LEU ASN LEU ASP PHE ASP THR GLY SER SER SEQRES 4 A 329 ASP LEU TRP VAL PHE SER SER GLU THR THR ALA SER GLU SEQRES 5 A 329 VAL SUI GLN THR ILE TYR THR PRO SER LYS SER THR THR SEQRES 6 A 329 ALA LYS LEU LEU SER GLY ALA THR TRP SER ILE SER TYR SEQRES 7 A 329 GLY ASP GLY SER SER SER SER GLY ASP VAL TYR THR ASP SEQRES 8 A 329 THR VAL SER VAL GLY GLY LEU THR VAL THR GLY GLN ALA SEQRES 9 A 329 VAL GLU SER ALA LYS LYS VAL SER SER SER PHE THR GLU SEQRES 10 A 329 ASP SER THR ILE ASP GLY LEU LEU GLY LEU ALA PHE SER SEQRES 11 A 329 THR LEU ASN THR VAL SER PRO THR GLN GLN LYS THR PHE SEQRES 12 A 329 PHE ASP ASN ALA LYS ALA SER LEU ASP SER PRO VAL PHE SEQRES 13 A 329 THR ALA ASP LEU GLY TYR HIS ALA PRO GLY THR TYR ASN SEQRES 14 A 329 PHE GLY PHE ILE ASP THR THR ALA TYR THR GLY SER ILE SEQRES 15 A 329 THR TYR THR ALA VAL SER THR LYS GLN GLY PHE TRP GLU SEQRES 16 A 329 TRP THR SER THR GLY TYR ALA VAL GLY SER GLY THR PHE SEQRES 17 A 329 LYS SER THR SER ILE ASP GLY ILE ALA ASP THR GLY THR SEQRES 18 A 329 THR LEU LEU TYR LEU PRO ALA THR VAL VAL SER ALA TYR SEQRES 19 A 329 TRP ALA GLN VAL SER GLY ALA LYS SER SER SER SER VAL SEQRES 20 A 329 GLY GLY TYR VAL PHE PRO CYS SER ALA THR LEU PRO SER SEQRES 21 A 329 PHE THR PHE GLY VAL GLY SER ALA ARG ILE VAL ILE PRO SEQRES 22 A 329 GLY ASP TYR ILE ASP PHE GLY PRO ILE SER THR GLY SER SEQRES 23 A 329 SER SER CYS PHE GLY GLY ILE GLN SER SER ALA GLY ILE SEQRES 24 A 329 GLY ILE ASN ILE PHE GLY ASP VAL ALA LEU LYS ALA ALA SEQRES 25 A 329 PHE VAL VAL PHE ASN GLY ALA THR THR PRO THR LEU GLY SEQRES 26 A 329 PHE ALA SER LYS SEQRES 1 I 10 PRO HIS PRO PHE HIS STA VAL ILE HIS LYS MODRES 1GVU SUI A 54 ASP MODRES 1GVU SUI A 54 GLY HET SUI A 54 11 HET STA I 406 11 HET SO4 A 500 5 HET SO4 A 501 5 HETNAM SUI (3-AMINO-2,5-DIOXO-1-PYRROLIDINYL)ACETIC ACID HETNAM STA STATINE HETNAM SO4 SULFATE ION FORMUL 1 SUI C6 H8 N2 O4 FORMUL 2 STA C8 H17 N O3 FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *462(H2 O) HELIX 1 1 THR A 49 VAL A 53 5 5 HELIX 2 2 THR A 60 SER A 64 5 5 HELIX 3 3 SER A 113 ASP A 119 1 7 HELIX 4 4 PHE A 130 ASN A 134 5 5 HELIX 5 5 THR A 143 LYS A 149 1 7 HELIX 6 6 PRO A 228 ALA A 237 1 10 HELIX 7 7 PRO A 274 ILE A 278 1 5 HELIX 8 8 GLY A 306 LYS A 311 1 6 SHEET 1 AA 3 LYS A 68 SER A 78 0 SHEET 2 AA 3 SER A 84 VAL A 96 -1 O SER A 85 N ILE A 77 SHEET 3 AA 3 TYR A 17 ILE A 23 -1 O GLN A 22 N SER A 95 SHEET 1 AB 7 LYS A 68 SER A 78 0 SHEET 2 AB 7 SER A 84 VAL A 96 -1 O SER A 85 N ILE A 77 SHEET 3 AB 7 LEU A 99 VAL A 112 -1 O LEU A 99 N VAL A 96 SHEET 4 AB 7 LEU A 41 VAL A 43 1 O LEU A 41 N GLU A 107 SHEET 5 AB 7 GLY A 124 GLY A 127 -1 O LEU A 125 N TRP A 42 SHEET 6 AB 7 GLN A 28 ASP A 35 1 O ASP A 33 N LEU A 126 SHEET 7 AB 7 TYR A 17 ILE A 23 -1 O THR A 19 N LEU A 32 SHEET 1 AC 7 ALA A 269 ILE A 273 0 SHEET 2 AC 7 PHE A 262 VAL A 266 -1 O PHE A 262 N ILE A 273 SHEET 3 AC 7 GLU A 196 VAL A 204 -1 N THR A 200 O GLY A 265 SHEET 4 AC 7 LYS A 210 ALA A 218 -1 O LYS A 210 N TYR A 202 SHEET 5 AC 7 ASN A 303 PHE A 305 1 O ASN A 303 N ILE A 217 SHEET 6 AC 7 LEU A 225 LEU A 227 -1 O TYR A 226 N ILE A 304 SHEET 7 AC 7 ILE A 294 SER A 296 1 O GLN A 295 N LEU A 227 SHEET 1 AD 4 LYS A 243 SER A 245 0 SHEET 2 AD 4 GLY A 250 PRO A 254 -1 O GLY A 250 N SER A 245 SHEET 3 AD 4 SER A 289 GLY A 292 -1 O CYS A 290 N PHE A 253 SHEET 4 AD 4 ASP A 279 PRO A 282 -1 N PHE A 280 O PHE A 291 SSBOND 1 CYS A 255 CYS A 290 1555 1555 2.06 LINK C VAL A 53 N SUI A 54 1555 1555 1.37 LINK C SUI A 54 N GLN A 56 1555 1555 1.36 LINK C HIS I 405 N STA I 406 1555 1555 1.34 LINK C STA I 406 N VAL I 407 1555 1555 1.36 CISPEP 1 THR A 25 PRO A 26 0 -8.02 CISPEP 2 SER A 137 PRO A 138 0 6.26 SITE 1 AC1 10 SER A 113 SER A 114 THR A 322 HOH A2173 SITE 2 AC1 10 HOH A2213 HOH A2448 HOH A2449 HOH A2450 SITE 3 AC1 10 HOH A2451 HOH A2452 SITE 1 AC2 3 SER A 137 PRO A 138 HOH A2158 SITE 1 AC3 20 ASP A 15 ASP A 33 ASP A 35 GLY A 37 SITE 2 AC3 20 SER A 78 TYR A 79 GLY A 80 ASP A 81 SITE 3 AC3 20 ASP A 119 ILE A 122 ASP A 219 GLY A 221 SITE 4 AC3 20 THR A 222 THR A 223 ILE A 304 HOH A2349 SITE 5 AC3 20 HOH I2005 HOH I2006 HOH I2007 HOH I2009 CRYST1 42.477 75.779 42.987 90.00 95.43 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023542 0.000000 0.002238 0.00000 SCALE2 0.000000 0.013196 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023368 0.00000